Dr Naci’s research focuses on pharmaceutical regulation, health policy evaluation, and the comparative effectiveness of new and existing interventions in health care. His work has appeared in top journals in the field, including the BMJ, JAMA, and Health Affairs.
Prior to joining LSE, he was a Thomas O. Pyle Fellow in Population Medicine at Harvard University (2013-2014) and a Fellow in Pharmaceutical Policy Research at Harvard Medical School and Harvard Pilgrim Health Care Institute (2012-2013), both in Boston, USA.
Dr Naci received his Doctor of Philosophy (PhD) in Pharmaceutical Policy from the London School of Economics and Political Science (London, UK); his Master of Science in Public Health (MSPH) degree in International Health, with a focus on Health Economics from the Johns Hopkins University Bloomberg School of Public Health (Baltimore, MD, USA); and his Bachelor of Arts degree in Biochemistry from Knox College (Galesburg, IL, USA).
Expertise: cardiovascular disease; comparative effectiveness research; health technology; health policy; health care; pharmaceutical regulation; research design; systematic reviews